Systemic Manifestations of RSV-Bronchiolitis Beyond the Lungs

Objective: To evaluate the extrapulmonary manifestations in infants and young children admitted with PCR- confirmed RSV bronchiolitis and to examine their relationship with clinical acuity and in-hospital outcomes. Methodology: A prospective observational study was carried out in the Department of Pediatrics, Federal Government Polyclinic Hospital, Islamabad from November 2025 to February 2026. in children aged 1-48 months with PCR-confirmed RSV bronchiolitis. Patients with other viral or bacterial co-infection or chronic medical conditions were excluded. They were assessed for neurological, cardiovascular, gastrointestinal, and metabolic manifestations during hospitalization. The demographic data, clinical observations, laboratory values, level of care, respiratory support, the length of hospital stay, and outcomes were documented. Because a validated bronchiolitis severity score was not prospectively recorded, level of care was used as a pragmatic measure of clinical acuity; ward admission represented lower-acuity care and HDU/ICU admission higher-acuity care. The analysis of data was performed in SPSS 24, and the p-value < 0.05 was considered significant. Results: A total of 123 pediatric patients with RSV-bronchiolitis were enrolled. Extrapulmonary findings were observed with metabolic manifestations in 29.3% patients followed by gastrointestinal(27.6%), neurological(26.7%) and cardiovascular[A1] [D2] [HN3] (21%) involvement. Metabolic manifestations included hypocalcemia(15.4%), hyponatremia(9.8%), hypokalemia(8.1%), hyperkalemia(7.3%) and hypernatremia(0.8%). Gastrointestinal involvement was in the form of diarrhea(11%) and vomiting(9%). Neurological problems included seizures(18%) and altered level of consciousness(8%). Cardiovascular manifestations included myocarditis(11%), murmur(9%) and tachycardia(1%). The mean duration of hospital stay was 6.2±3.7 days. The average hospital stay was significantly longer among patients with cardiac manifestations, including tachycardia (9.14±6.6 days), murmurs (6.18±3.0 days), and myocarditis (7.0±0.0 days), compared with those without cardiac involvement (5.8±3.0 days; p=0.020). However, no significant difference in hospital stay was observed in patients with gastrointestinal (p=0.127) and neurological manifestations (p=0.127). In severity-stratified analysis, any extrapulmonary manifestation occurred in 59.6% of ward patients and 70.6% of HDU/ICU patients (p=0.302); no individual system showed a statistically significant difference between the two groups. Amongst the six recorded deaths, 50% of patients had associated metabolic derangements. Conclusion: RSV bronchiolitis demonstrates substantial multisystem involvement in hospitalized children with PCR-confirmed RSV bronchiolitis which were not confined to patients requiring HDU/ICU care. Cardiovascular involvement was associated with a longer hospital stay, while no statistically significant severity-based difference was demonstrated for individual extrapulmonary systems. Early recognition of these extrapulmonary manifestations is crucial to improve clinical outcome and optimize treatment.

Authors

Institutions

Publication Details

Journal
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
Published
2026-11-21
DOI
https://doi.org/10.48036/09m0k065
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Systemic Manifestations of RSV-Bronchiolitis Beyond the Lungs

Maham Zahid, Awais Abid, Rabia Tabassum, Hina Naveed et al.
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
Respiratory viral infections research
article

Systemic Manifestations of RSV-Bronchiolitis Beyond the Lungs

Maham Zahid, Awais Abid, Rabia Tabassum, Hina Naveed, Naveed Ashraf, Abdul Salam Wazir, Shahzad Munir
article en

Abstract

Objective: To evaluate the extrapulmonary manifestations in infants and young children admitted with PCR- confirmed RSV bronchiolitis and to examine their relationship with clinical acuity and in-hospital outcomes. Methodology: A prospective observational study was carried out in the Department of Pediatrics, Federal Government Polyclinic Hospital, Islamabad from November 2025 to February 2026. in children aged 1-48 months with PCR-confirmed RSV bronchiolitis. Patients with other viral or bacterial co-infection or chronic medical conditions were excluded. They were assessed for neurological, cardiovascular, gastrointestinal, and metabolic manifestations during hospitalization. The demographic data, clinical observations, laboratory values, level of care, respiratory support, the length of hospital stay, and outcomes were documented. Because a validated bronchiolitis severity score was not prospectively recorded, level of care was used as a pragmatic measure of clinical acuity; ward admission represented lower-acuity care and HDU/ICU admission higher-acuity care. The analysis of data was performed in SPSS 24, and the p-value < 0.05 was considered significant. Results: A total of 123 pediatric patients with RSV-bronchiolitis were enrolled. Extrapulmonary findings were observed with metabolic manifestations in 29.3% patients followed by gastrointestinal(27.6%), neurological(26.7%) and cardiovascular[A1] [D2] [HN3] (21%) involvement. Metabolic manifestations included hypocalcemia(15.4%), hyponatremia(9.8%), hypokalemia(8.1%), hyperkalemia(7.3%) and hypernatremia(0.8%). Gastrointestinal involvement was in the form of diarrhea(11%) and vomiting(9%). Neurological problems included seizures(18%) and altered level of consciousness(8%). Cardiovascular manifestations included myocarditis(11%), murmur(9%) and tachycardia(1%). The mean duration of hospital stay was 6.2±3.7 days. The average hospital stay was significantly longer among patients with cardiac manifestations, including tachycardia (9.14±6.6 days), murmurs (6.18±3.0 days), and myocarditis (7.0±0.0 days), compared with those without cardiac involvement (5.8±3.0 days; p=0.020). However, no significant difference in hospital stay was observed in patients with gastrointestinal (p=0.127) and neurological manifestations (p=0.127). In severity-stratified analysis, any extrapulmonary manifestation occurred in 59.6% of ward patients and 70.6% of HDU/ICU patients (p=0.302); no individual system showed a statistically significant difference between the two groups. Amongst the six recorded deaths, 50% of patients had associated metabolic derangements. Conclusion: RSV bronchiolitis demonstrates substantial multisystem involvement in hospitalized children with PCR-confirmed RSV bronchiolitis which were not confined to patients requiring HDU/ICU care. Cardiovascular involvement was associated with a longer hospital stay, while no statistically significant severity-based difference was demonstrated for individual extrapulmonary systems. Early recognition of these extrapulmonary manifestations is crucial to improve clinical outcome and optimize treatment.

Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical UniversityVol. 22(5)
Khyber Medical University (PK)
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon